Etybenzatropine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (1R,5R)-3-(dicyclohexylmethoxy)-8-ethyl- 8-azabicyclo[3.2.1]octane |
|
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral, IM, IV |
| Identifiers | |
| CAS number | 524-83-4 |
| ATC code | N04AC30 |
| PubChem | CID 71637 |
| ChemSpider | 16736129 |
| UNII | G1X2X9N95N |
| KEGG | D04087 |
| Chemical data | |
| Formula | C22H27NO |
| Mol. mass | 321.456 g/mol |
|
|
|
|
| |
|
Etybenzatropine (INN), also known as ethybenztropine (USAN, BAN) and tropethydrylin, is an anticholinergic/antihistamine marketed under the trade names Panolid, Ponalid, and Ponalide, which is used as an antiparkinsonian agent. Like its analogue benzatropine, it may act as a dopamine reuptake inhibitor.[citation needed]
See also[edit]
References[edit]
|
|||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |